GB9422836D0 - Monitoring malignant disease - Google Patents
Monitoring malignant diseaseInfo
- Publication number
- GB9422836D0 GB9422836D0 GB9422836A GB9422836A GB9422836D0 GB 9422836 D0 GB9422836 D0 GB 9422836D0 GB 9422836 A GB9422836 A GB 9422836A GB 9422836 A GB9422836 A GB 9422836A GB 9422836 D0 GB9422836 D0 GB 9422836D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- malignant disease
- monitoring malignant
- monitoring
- disease
- malignant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9422836A GB9422836D0 (en) | 1994-11-11 | 1994-11-11 | Monitoring malignant disease |
| PCT/GB1995/002647 WO1996015263A1 (en) | 1994-11-11 | 1995-11-10 | Monitoring malignant disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9422836A GB9422836D0 (en) | 1994-11-11 | 1994-11-11 | Monitoring malignant disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9422836D0 true GB9422836D0 (en) | 1995-01-04 |
Family
ID=10764275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9422836A Pending GB9422836D0 (en) | 1994-11-11 | 1994-11-11 | Monitoring malignant disease |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB9422836D0 (en) |
| WO (1) | WO1996015263A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2253002A1 (en) * | 1998-03-25 | 1999-09-25 | Sabine Mai | Method and marker for identification of premalignancy and malignancy and therapeutic intervention |
| CN100347316C (en) * | 2005-02-04 | 2007-11-07 | 上海第二医科大学附属瑞金医院 | AML-1 matator as one of leuckemia quick change major gene and its use |
| CN100453652C (en) * | 2005-02-04 | 2009-01-21 | 上海第二医科大学附属瑞金医院 | Method for detecting AML-1 mutant gene as one of leukaemia acute change major genes and its use |
| EP2557421A3 (en) * | 2007-03-23 | 2013-06-05 | King's College London | Altered mitochondrial activity in diseases resulting from oxidative stress |
| WO2013192423A2 (en) | 2012-06-20 | 2013-12-27 | Eutropics Pharmaceuticals, Inc. | Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives |
| WO2014081953A1 (en) | 2012-11-21 | 2014-05-30 | Richard David J | Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivatives |
| US10732182B2 (en) | 2013-08-01 | 2020-08-04 | Eutropics Pharmaceuticals, Inc. | Method for predicting cancer sensitivity |
| US10640803B2 (en) | 2013-10-30 | 2020-05-05 | Eutropics Pharmaceuticals, Inc. | Methods for determining chemosensitivity and chemotoxicity |
| US10793915B2 (en) | 2015-01-12 | 2020-10-06 | Eutropics Pharmaceuticals, Inc. | Context dependent diagnostics test for guiding cancer treatment |
| US11242559B2 (en) * | 2015-01-13 | 2022-02-08 | The Chinese University Of Hong Kong | Method of nuclear DNA and mitochondrial DNA analysis |
| KR20180018507A (en) | 2015-04-20 | 2018-02-21 | 톨레로 파마수티컬스, 인크. | Prediction of Response to Albosis Dip by Mitochondrial Profiling |
| MX2017014645A (en) | 2015-05-18 | 2018-01-23 | Tolero Pharmaceuticals Inc | Alvocidib prodrugs having increased bioavailability. |
| WO2017024073A1 (en) | 2015-08-03 | 2017-02-09 | Tolero Pharmaceuticals, Inc. | Combination therapies for treatment of cancer |
| WO2018094275A1 (en) | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
| CN110234659A (en) | 2016-12-19 | 2019-09-13 | 特雷罗药物股份有限公司 | Analytical peptide and method for sensitivity analysis |
| US11497756B2 (en) | 2017-09-12 | 2022-11-15 | Sumitomo Pharma Oncology, Inc. | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib |
| CA3119807A1 (en) | 2018-12-04 | 2020-06-11 | Sumitomo Dainippon Pharma Oncology, Inc. | Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer |
| JP2022525149A (en) | 2019-03-20 | 2022-05-11 | スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド | Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure |
-
1994
- 1994-11-11 GB GB9422836A patent/GB9422836D0/en active Pending
-
1995
- 1995-11-10 WO PCT/GB1995/002647 patent/WO1996015263A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996015263A1 (en) | 1996-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0694307A4 (en) | Atopic disease remedy | |
| EP0706781A3 (en) | Morcellator | |
| GB9422836D0 (en) | Monitoring malignant disease | |
| GB2325519B (en) | Physiological movement monitoring | |
| DE69517588D1 (en) | Gekühlter transportcontainer | |
| AU122938S (en) | Breadbox | |
| SK5595A3 (en) | Built-in mechanizm | |
| GB2295534B (en) | Scraper | |
| PL312691A1 (en) | New substituted benzyimidazole | |
| ZA958215B (en) | Microbicides | |
| GB2331742A9 (en) | Monitoring | |
| SG69962A1 (en) | Indan | |
| CA75064S (en) | Drum | |
| PL302688A1 (en) | Blast-hole wadding | |
| GB9419382D0 (en) | Monitoring methods | |
| PL56634Y1 (en) | Strainer | |
| PL56068Y1 (en) | Bedside table-cabinet | |
| GB9422322D0 (en) | Electroencephalograph | |
| GB9621885D0 (en) | Diagnosis | |
| GB9621469D0 (en) | Diagnosis | |
| PL100757U1 (en) | Purse | |
| GB9409155D0 (en) | Draught - excluding unit | |
| AU122067S (en) | Shopfitting unit | |
| ZA953542B (en) | Microbicides | |
| GB9420238D0 (en) | Boundary monitor |